Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Miami Cardiovascular Innovations (MCVI) is a medical technology company and incubator based in Miami, Florida, dedicated to the development of minimally invasive cardiovascular devices. The company is best known for its work on the Ample vascular closure device, which targets the growing need for safe and effective closure of large-bore arterial access sites used in structural heart and endovascular procedures. Led by interventional cardiologist Dr. Pedro Martinez-Clark, MCVI focuses on bridging the gap between clinical unmet needs and commercialized medical solutions. The company's portfolio emphasizes improving patient outcomes and procedural efficiency in the catheterization lab through innovative engineering and clinical validation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Miami Cardiovascular Innovations.